FXAIX
Price
$266.59
Change
+$2.29 (+0.87%)
Updated
Sep 11 closing price
Net Assets
859.16B
LRMAX
Price
$27.65
Change
+$0.13 (+0.47%)
Updated
Sep 11 closing price
Net Assets
4.94B
Interact to see
Advertisement

FXAIX vs LRMAX

FXAIX vs LRMAX Comparison Chart in %
View a ticker or compare two or three
VS
FXAIX vs. LRMAX commentary
Sep 13, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FXAIX is a Buy and LRMAX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
FXAIX has more cash in the bank: 859B vs. LRMAX (4.94B). FXAIX pays higher dividends than LRMAX: FXAIX (1.03) vs LRMAX (0.81). FXAIX was incepted earlier than LRMAX: FXAIX (15 years) vs LRMAX (9 years). LRMAX (0.59) is less costly to investors than FXAIX (0.01). LRMAX is a more actively managed with annual turnover of: 30.00 vs. FXAIX (3.00). FXAIX (0) and LRMAX (0) have matching initial minimum investment requirements. FXAIX annual gain was more profitable for investors over the last year : 16.58 vs. LRMAX (6.52). FXAIX return over 5 years is better than : 82.76 vs. LRMAX (35.25).
FXAIXLRMAXFXAIX / LRMAX
Total Expense Ratio0.010.593%
Annual Report Gross Expense Ratio0.010.593%
Fund Existence15 years9 years-
Gain YTD11.7908.097146%
Front LoadN/AN/A-
Min. Initial Investment00-
Min. Initial Investment IRAN/AN/A-
Net Assets859B4.94B17,396%
Annual Yield % from dividends1.030.81128%
Returns for 1 year16.586.52254%
Returns for 3 years76.9050.25153%
Returns for 5 years82.7635.25235%
Returns for 10 years294.63N/A-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CEVA29.011.05
+3.76%
CEVA
BIIB217.151.72
+0.80%
Biogen
LUCD0.78-0.02
-2.64%
Lucid Diagnostics
MBAI6.40-0.20
-3.03%
MBody AI Ltd
ELVN54.32-1.91
-3.40%
Enliven Therapeutics